Embecta Corp. (EMBC) vs Orchestra BioMed Holdings, Inc. (OBIO)

A side-by-side comparison of Embecta Corp. and Orchestra BioMed Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Embecta Corp. logo
EMBC
Embecta Corp.
$362M
$6.10HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Orchestra BioMed Holdings, Inc. logo
OBIO
Orchestra BioMed Holdings, Inc.
$350M
$5.84HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — EMBC vs OBIO

growth of $100 · dividends reinvested · last 5y
EMBC -85.5% (-32.1%/yr)OBIO -39.1% (-9.4%/yr)OBIO compounded faster over this window
050100150200Start $1002023202420252026$14$61
EMBC OBIO

EMBC vs OBIO: by the numbers

  • •EMBC is the larger company ($362M vs $350M market cap).
  • •EMBC is profitable (8.59% net margin) while OBIO runs a net loss (-184.60%).
  • •OBIO grew revenue faster over the past five years (148.45% vs -0.09% CAGR).
  • •EMBC pays a dividend (5.44% yield), while OBIO has no payments in the available dividend history.

Metrics side by side

Valuation

MetricEMBCOBIO
P/E ratio4.12N/A
Forward P/E3.46N/A
P/S ratio0.3510.94
P/B ratioN/A18.10
EV / EBITDA5.40N/A
FCF yield45.52%N/A

Profitability

MetricEMBCOBIO
Gross margin59.89%99.32%
Operating margin24.85%-154.73%
Net margin8.59%-184.60%
ROEN/A-200.64%
ROIC17.99%-56.73%

Dividends

MetricEMBCOBIO
Dividend yield5.44%N/A
Payout ratio21.62%N/A

Growth (annualized)

MetricEMBCOBIO
Revenue CAGR (5Y)-0.09%148.45%
EPS CAGR (5Y)-26.22%N/A
FCF CAGR (5Y)-16.77%N/A
Total return CAGR (5Y)N/A-9.35%

Frequently asked

Which has grown faster, EMBC or OBIO?
Over the past five years, OBIO grew revenue faster — EMBC at a -0.09% CAGR versus OBIO at 148.45%.
Does EMBC or OBIO pay a bigger dividend?
EMBC pays a dividend (5.44% yield), while OBIO has no payments in the available dividend history.
Is EMBC or OBIO more profitable?
EMBC runs the higher net margin — EMBC at 8.59% versus OBIO at -184.60%.

Go deeper

Full EMBC analysisFull OBIO analysisInteractive comparison tool

Dig into the metrics

Embecta P/E ratioEmbecta dividend yieldEmbecta ROEOrchestra BioMed ROEEmbecta operating marginOrchestra BioMed operating marginEmbecta revenue growthOrchestra BioMed revenue growthEmbecta free cash flowOrchestra BioMed free cash flow

Embecta & Orchestra BioMed appear in these rankings

Highest Dividend Yield StocksFastest Revenue Growth StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.